For the Inventor, By the Inventor

Enter assignee name

New York, NY, United States of America

Unl Holdings LLC

USPTO Granted Patents = 61

% Expired Patents = 11.5

EPO Patents = 35

Forward Citations = 487

Loading Chart...

Loading Chart...

76 inventors (with patents filed for the assignee):

Ian B Hanson (25 out of 144 patents)

Paul F Bente, Iv (24 out of 78 patents)

Kevin Lee Bokelman (15 out of 52 patents)

4. Sean M O'connor (14 out of 26 patents)

5. Nicholas J Ciccarelli (9 out of 16 patents)

6. Robert Scott Russo (8 out of 10 patents)

7. Ryan Michael Agard (8 out of 33 patents)

8. Philip A Weaver (8 out of 10 patents)

9. Gautam N Shetty (8 out of 21 patents)

10. Peter J Dungar (6 out of 8 patents)

11. Katlin Marie Lumme (6 out of 7 patents)

12. Matthew J Clemente (6 out of 23 patents)

13. Brandon J McKee (5 out of 9 patents)

14. Craig Stephen Thorley (5 out of 24 patents)

15. Joseph Hermes Kaal (5 out of 22 patents)

Core Competencies:

Controlled Drug Delivery

Retractable Syringes

Dual Chamber Mixing

Auto-Injectors

Fluid Pathway Connection

Drug Delivery Pumps

Vaccine Syringes

Accurate Dose Control

Plunger Devices

Targeted Delivery

Sensor Systems

Needle Safety Mechanisms

61 patents: Sort by Forward Citations

1. 12053614 - Systems and methods for controlled drug delivery pumps (2024-08-06),

2. 11865310 - Handheld drug delivery device (2024-01-09),

3. 11484644 - Sterile fluid pathway connection to drug containers for drug delivery pumps (2022-11-01),

4. 11298466 - Needle capture retractable needle safety syringes (2022-04-12),

5. 11241545 - Retractable syringe with improved delivery efficiency and locking system (2022-02-08),

6. 11229747 - Expanding plunger rods for syringes (2022-01-25),

7. 11191902 - Combination plunger device for a dual chamber mixing syringe (2021-12-07),

8. 11173244 - Drive mechanism for drug delivery pumps with integrated status indication (2021-11-16),

9. 11135356 - Controlled delivery drive mechanisms for drug delivery pumps (2021-10-05),

10. 11071825 - Actuation mechanisms for dual chamber mixing syringes (2021-07-27),

11. 11058826 - Vaccination syringe (2021-07-13),

12. D923177 - Drug delivery pump (2021-06-22),

13. 11040135 - Integrated pierceable seal fluid pathway connection and drug containers for drug delivery pumps (2021-06-22),

14. 11033689 - Plunger-driven auto-injectors (2021-06-15),

15. 11033679 - Fill-finish cartridges for sterile fluid pathway assemblies and drug delivery devices incorporating fill-finish cartridges (2021-06-15),

Company Overview

Unl Holdings LLC, based in New York, specializes in the development and manufacturing of advanced drug delivery devices. The company focuses on innovative solutions such as controlled drug delivery systems, retractable syringes, and dual chamber mixing technologies. Their expertise extends to auto-injectors, fluid pathway connections, and drug delivery pumps, ensuring accurate dose control for various applications, including vaccine administration. Unl Holdings is committed to enhancing patient care through cutting-edge medical device technology.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

61 Patents

#161 in New York, NY

#352 in New York

#5,917 in US

#11,930 in the World

New York, NY, United States of America

Unl Holdings LLC

Forward Citations = 487

76 inventors:

Ian B Hanson (25 out of 144 patents)

Paul F Bente, Iv (24 out of 78 patents)

Kevin Lee Bokelman (15 out of 52 patents)

4. Sean M O'connor (14 out of 26 patents)

5. Nicholas J Ciccarelli (9 out of 16 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Unl Holdings LLC. Retrieved from https://idiyas.com/company/unl-holdings

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…